This is a StreetInsider.com Premium Only Page

Syndax Pharmaceuticals (SNDX) – Hot New Coverage

Jul 11, 2023 06:19 AM Guggenheim Starts Syndax Pharmaceuticals (SNDX) at Buy; bullish on lead asset revumenib

Feb 14, 2022 04:32 PM UPDATE: Goldman Sachs Starts Syndax Pharmaceuticals (SNDX) at Buy

Jan 7, 2019 02:56 PM

Jan 3, 2019 04:11 PM

Jul 12, 2018 07:17 AM

Jan 5, 2018 06:14 AM

Mar 24, 2017 05:39 AM

Mar 16, 2017 06:51 AM

Dec 30, 2016 07:49 AM

Mar 31, 2016 07:09 AM